Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FF/levocabastine FDC in Allergic Rhinitis
NCT01957202Phase 2Completed
- Sponsor
- GSK
- Start
- Oct 2013
- Primary completion
- Feb 2014
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of fluticasone, levocabastine in allergic rhinitis (AR), sponsored by GSK. Started Oct 2013; status: completed.
02
Drugs
fluticasonelevocabastine
03
Conditions
allergic rhinitis (AR)
Beyond the preview
Go deeper on NCT01957202.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01957202.